Gabather AB
GABA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010869552 (+1 more)
- LEI:
- 549300VLUOMD0TE1O093
- Country:
- Sweden
- Address:
- FORSKARGATAN 20 J, 151 36 Södertälje
- Website:
- https://gabather.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Gabather AB is a clinical-stage pharmaceutical company developing a new generation of therapeutics for neuropsychiatric disorders. The company's proprietary drug candidates are designed to modulate the GABAA receptor system, aiming to restore balance in the brain and enhance cognitive function. Its most advanced candidate, GT-002, has successfully completed Phase I clinical trials. Gabather targets areas with significant unmet medical needs, including antipsychotics, antidepressants, anxiolytics, analgesics, and cognition-enhancing treatments for conditions such as Alzheimer's disease. The company's research is founded on over a decade of work at Lund University and the Research Institute of Biological Psychiatry.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Gabather AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Gabather AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Gabather AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
